Literature DB >> 11529767

A streamlined synthesis for 2,3-dihydroxyterephthalamides.

C J Gramer1, K N Raymond.   

Abstract

[reaction: see text]. 2,3-Dihydroxyterephthalamides have been synthesized through a route that avoids the protection and deprotection of the phenol groups. The procedure allows for symmetric and unsymmetric amide linkages. This synthetic sequence significantly decreases the time and cost of preparation and increases the overall yield of this class of metal chelators.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529767     DOI: 10.1021/ol016253u

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  A bidentate terephthalamide ligand, TAMmeg, as an entry into terephthalamide-containing therapeutic iron chelating agents.

Authors:  Kristy M Clarke Jurchen; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2006-03-20       Impact factor: 5.165

2.  Synthesis and anion recognition properties of shape-persistent binaphthyl-containing chiral macrocyclic amides.

Authors:  Marco Caricato; Nerea Jordana Leza; Claudia Gargiulli; Giuseppe Gattuso; Daniele Dondi; Dario Pasini
Journal:  Beilstein J Org Chem       Date:  2012-06-28       Impact factor: 2.883

3.  Shedding Light on the Interactions of Hydrocarbon Ester Substituents upon Formation of Dimeric Titanium(IV) Triscatecholates in DMSO Solution.

Authors:  A Carel N Kwamen; Marcel Schlottmann; David Van Craen; Elisabeth Isaak; Julia Baums; Li Shen; Ali Massomi; Christoph Räuber; Benjamin P Joseph; Gerhard Raabe; Christian Göb; Iris M Oppel; Rakesh Puttreddy; Jas S Ward; Kari Rissanen; Roland Fröhlich; Markus Albrecht
Journal:  Chemistry       Date:  2020-01-22       Impact factor: 5.236

4.  Catechol Thioesters: Ligands for Hierarchically Formed Lithium-Bridged Titanium(IV) Helicates and Helicate-Based Switches.

Authors:  A Carel N Kwamen; Gilles S de Macedo; Constanze Wiederhold; Iris M Oppel; Markus Albrecht
Journal:  Chemistry       Date:  2020-03-05       Impact factor: 5.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.